Pitfalls in hemoglobin A1c measurement: when results may be misleading
- PMID: 24002631
- PMCID: PMC3912281
- DOI: 10.1007/s11606-013-2595-x
Pitfalls in hemoglobin A1c measurement: when results may be misleading
Abstract
Since the beginning of clinical use in the 1970s, hemoglobin A1c (A1c) has become the standard tool for monitoring glycemic control in patients with diabetes. The role of the A1c test was broadened in 2010, when the American Diabetes Association added A1c as a diagnostic criterion for diabetes. Because of hemoglobin A1c's integral role in diagnosis and treatment, it is important to recognize clinical scenarios and interfering factors that yield false results. The purpose of this review is to describe the A1c measurement, outline clinical scenarios or factors that may yield false results, and describe alternative laboratory biomarkers.
Comment in
-
Capsule commentary on Radin, pitfalls in hemoglobin A1c measurement: when results may be misleading.J Gen Intern Med. 2014 Feb;29(2):363. doi: 10.1007/s11606-013-2632-9. J Gen Intern Med. 2014. PMID: 24065382 Free PMC article. No abstract available.
References
-
- Steinberg MH, Benz EJ Jr, Adewoye AH, Ebert BL. Hemoglobin synthesis, structure, and function. In: Hematology: Basic Principles and Practice. 5th ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2009. Chap 33.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
